BACKGROUND:Adolescents excluded from mainstream education have high mental health needs. The use of computerized Cognitive Behavioural Therapy (cCBT) has not been investigated with this group. AIMS: To test the efficacy of the SPARX cCBT programme for symptoms of depression among adolescents in programmes for students excluded or alienated from mainstream education. METHOD: Adolescents (32; 34% Maori, 38% Pacific Island, 56% male) aged 13-16 with Child Depression Rating Scale Revised (CDRS-R) scores indicating possible through to almost certain depressive disorder were randomized to SPARX to be completed over the following 5 weeks (n = 20) or to waitlist control (n = 12). Assessments were at baseline, 5 weeks and 10 weeks. Those in the wait condition were invited to complete SPARX after the 5 week assessment. RESULTS: Most participants (n = 26, 81%) completed at least 4 levels of SPARX and 22 (69%) completed all 7 levels. Among the 30 (94%) participants who began treatment as randomized and provided 5-week data, significant differences were found between cCBT and wait groups on the CDRS-R (baseline to 5-week mean change -14.7 versus -1.1, p<.001), remission (78% vs. 36%, p = .047) and on the Reynolds Adolescent Depression Scale (-4.6 vs. +3.2 p = .05) but not on other self-rating psychological functioning scales. In intent-to-treat analyses CDRS-R changes and remission remained significant. Gains were maintained at 10-week follow-up. CONCLUSIONS:SPARX appears to be a promising treatment for students with symptoms of depression who are in alternative schooling programmes for those excluded from mainstream education.
RCT Entities:
BACKGROUND: Adolescents excluded from mainstream education have high mental health needs. The use of computerized Cognitive Behavioural Therapy (cCBT) has not been investigated with this group. AIMS: To test the efficacy of the SPARXcCBT programme for symptoms of depression among adolescents in programmes for students excluded or alienated from mainstream education. METHOD: Adolescents (32; 34% Maori, 38% Pacific Island, 56% male) aged 13-16 with ChildDepression Rating Scale Revised (CDRS-R) scores indicating possible through to almost certain depressive disorder were randomized to SPARX to be completed over the following 5 weeks (n = 20) or to waitlist control (n = 12). Assessments were at baseline, 5 weeks and 10 weeks. Those in the wait condition were invited to complete SPARX after the 5 week assessment. RESULTS: Most participants (n = 26, 81%) completed at least 4 levels of SPARX and 22 (69%) completed all 7 levels. Among the 30 (94%) participants who began treatment as randomized and provided 5-week data, significant differences were found between cCBT and wait groups on the CDRS-R (baseline to 5-week mean change -14.7 versus -1.1, p<.001), remission (78% vs. 36%, p = .047) and on the Reynolds Adolescent Depression Scale (-4.6 vs. +3.2 p = .05) but not on other self-rating psychological functioning scales. In intent-to-treat analyses CDRS-R changes and remission remained significant. Gains were maintained at 10-week follow-up. CONCLUSIONS:SPARX appears to be a promising treatment for students with symptoms of depression who are in alternative schooling programmes for those excluded from mainstream education.
Authors: Xinyu Zhou; Sarah E Hetrick; Pim Cuijpers; Bin Qin; Jürgen Barth; Craig J Whittington; David Cohen; Cinzia Del Giovane; Yiyun Liu; Kurt D Michael; Yuqing Zhang; John R Weisz; Peng Xie Journal: World Psychiatry Date: 2015-06 Impact factor: 49.548
Authors: Judy Garber; Steven M Brunwasser; Argero A Zerr; Karen T G Schwartz; Karen Sova; V Robin Weersing Journal: Depress Anxiety Date: 2016-10 Impact factor: 6.505
Authors: Javier Méndez; Óscar Sánchez-Hernández; Judy Garber; José P Espada; Mireia Orgilés Journal: Int J Environ Res Public Health Date: 2021-04-26 Impact factor: 3.390
Authors: Suzanne Archie; Lena Palaniyappan; Andrew T Olagunju; Natasha Johnson; Nicole Kozloff; Elham Sadeh; Andrea Bardell; Alexandra Baines; Kelly K Anderson; Oyedeji Ayonrinde; Manuela Ferrari Journal: JMIR Res Protoc Date: 2022-05-20
Authors: Manuela Ferrari; Judith Sabetti; Sarah V McIlwaine; Sahar Fazeli; S M Hani Sadati; Jai L Shah; Suzanne Archie; Katherine M Boydell; Shalini Lal; Joanna Henderson; Mario Alvarez-Jimenez; Neil Andersson; Rune Kristian Lundedal Nielsen; Jennifer A Reynolds; Srividya N Iyer Journal: Front Digit Health Date: 2022-04-07